Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice
- PMID: 8112859
- PMCID: PMC186198
- DOI: 10.1128/iai.62.3.887-891.1994
Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice
Abstract
A simple animal model was used to demonstrate passive protection by immunoglobulin A (IgA) against a mucosal pathogen, Vibrio cholerae. Oral administration of a monoclonal IgA directed against a lipopolysaccharide component of the vibrio protected neonatal mice against oral challenge, as measured by reduced intestinal colonization. A single dose of 0.1 microgram of polymeric monoclonal IgA given 1 h prior to challenge reduced the number of recoverable vibrios by at least 100-fold. An additional dose 3 h before challenge or 1 h after challenge did not enhance protection. A 10-fold-higher concentration of monomeric IgA was required to achieve the same level of protection as that conferred by polymeric IgA. Polymeric IgA digested with trypsin or human duodenal aspirates to lower-molecular-weight fragments retained most of its ability to protect mice against challenge.
Similar articles
-
Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.Infect Immun. 1993 Dec;61(12):5279-85. doi: 10.1128/iai.61.12.5279-5285.1993. Infect Immun. 1993. PMID: 8225601 Free PMC article.
-
Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.Infect Immun. 2015 Apr;83(4):1674-83. doi: 10.1128/IAI.02856-14. Epub 2015 Feb 9. Infect Immun. 2015. PMID: 25667263 Free PMC article.
-
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.Infect Immun. 1991 Mar;59(3):977-82. doi: 10.1128/iai.59.3.977-982.1991. Infect Immun. 1991. PMID: 1705246 Free PMC article.
-
Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139.J Med Microbiol. 2001 Jun;50(6):489-498. doi: 10.1099/0022-1317-50-6-489. J Med Microbiol. 2001. PMID: 11393286
-
[The immunology of cholera and the molecular biology of cholera toxin. Recent progress and future perspectives].Rev Alerg Mex. 1994 May-Jun;41(3):69-76. Rev Alerg Mex. 1994. PMID: 9377108 Review. Spanish.
Cited by
-
In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae.J Antimicrob Chemother. 2008 May;61(5):1103-9. doi: 10.1093/jac/dkn058. Epub 2008 Feb 29. J Antimicrob Chemother. 2008. PMID: 18310138 Free PMC article.
-
Ingested allergens must be absorbed systemically to induce systemic anaphylaxis.J Allergy Clin Immunol. 2011 Apr;127(4):982-9.e1. doi: 10.1016/j.jaci.2011.01.034. Epub 2011 Feb 26. J Allergy Clin Immunol. 2011. PMID: 21354602 Free PMC article.
-
Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.Antimicrob Agents Chemother. 1994 Dec;38(12):2785-91. doi: 10.1128/AAC.38.12.2785. Antimicrob Agents Chemother. 1994. PMID: 7695263 Free PMC article.
-
Therapeutic immunoglobulin A antibody for dysbiosis-related diseases.Int Immunol. 2021 Nov 25;33(12):787-790. doi: 10.1093/intimm/dxab066. Int Immunol. 2021. PMID: 34492105 Free PMC article. Review.
-
Purification and characterization of novel hemagglutinins from Vibrio mimicus: a 39-kilodalton major outer membrane protein and lipopolysaccharide.Infect Immun. 1996 Oct;64(10):4035-41. doi: 10.1128/iai.64.10.4035-4041.1996. Infect Immun. 1996. PMID: 8926065 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous